The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Latham & Watkins LLP

885 THIRD AVENUE, NEW YORK, NY 10022-4834, USA
Tel:
Work +1 212 906 1200
Fax:
Fax +1 212 751 4864
Email:
Web:
www.lw.com

Nathan Ajiashvili

Tel:
Work 2129062916
Email:
Web:
www.lw.com
Latham & Watkins LLP

Work Department

Nathan Ajiashvili is a partner in the New York office of Latham & Watkins. Mr. Ajiashvili is a member of the Corporate Department and Capital Markets, Private Equity Finance and Public Company Representation practices.  Nathan Ajiashvili represents both financial institutions and issuers engaging in equity and debt capital markets transactions in a broad array of industries, including life sciences, pharmaceuticals, retail and consumer products, hospitality, gaming, defense, automotive and technology.

Position

Corporate Partner

Career

https://www.lw.com/people/nathan-ajiashvili


United States: Finance

Capital markets: equity offerings

Within: Next generation lawyers

Nathan Ajiashvili - Latham & Watkins LLP

Within: Capital markets: equity offerings

The ‘standout tier-one practice’ at Latham & Watkins LLP really ‘covers the waterfront for capital markets deals’, according to sources. Widely recognized for its ‘spectacular senior partners’ and ‘collaborative style’, the team had a banner year, which saw it rank among the top two firms for US equity offerings by deal value for both issuers and managers. The technology sector, in line with market trends, was a primary source of instructions over the past year, but the diverse group also secured high-profile mandates relating to the life sciences and retail industries. Among its recent headlines, global corporate chair Marc Jaffe, held up as ‘the go-to specialist in the capital markets space’, teamed up with Gregory Rodgers and Benjamin Cohen to advise Spotify Technology on its groundbreaking direct listing on the NYSE. Jaffe also acted alongside global capital markets co-chair Ian Schuman (‘an immense deal-maker’) and the London office to assist Farfetch with its $1bn IPO and private placement. On the manager side, Washington DC-based Rachel Sheridan advised Morgan Stanley and JP Morgan as underwriters on Carbon Black’s $174.8m IPO. The group also includes Michael Benjamin and Senet Bischoff and up-and-coming partner Nathan Ajiashvili. Named partners are based in New York, unless otherwise stated.

[back to top]

United States: Industry focus

Healthcare: life sciences

Within: Healthcare: life sciences

Considered by clients as ‘superior’, Latham & Watkins LLP's life sciences practice stands out for its ‘expertise, breadth of capabilities, diligence and customer focus’. Washington DC’s regulatory expert John Manthei acted for pharmaceutical manufacturer Alvogen, obtaining a temporary restraining order preventing the State of Nevada from using medication distributed by the client in an execution. Manthei and Ben Haas (who is also based in Washington DC) assisted Endo and its subsidiary Par Sterile Products with a challenge to FDA’s implementation of the 2013 Drug Quality and Security Act (DQSA) in relation to the regulation of pharmaceutical compounding by outsourcing facilities. Silicon Valley’s Alan Mendelson represents emerging and public growth life sciences companies in a number of business transactions, including M&A, private placements and public offerings. The ‘fully engaged and very accessibleNathan Ajiashvili, who is based in New York and specializes in capital markets, and Washington DC’s associate Eitan Bernstein are also recommended.

[back to top]


Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to